Ultrahuman Secures $35 Million in Funding to Revolutionize Self-Quantification Technology

Ultrahuman, the world's most comprehensive self-quantification platform, is thrilled to announce that it has successfully raised $35 million in its latest funding round. This significant investment underscores the increasing interest in personal health technology and reinforces Ultrahuman's commitment to revolutionizing how individuals manage their well-being. With an innovative array of products including the Ultrahuman Ring AIR—the world’s lightest sleep-tracking wearable—and the Ultrahuman M1 continuous glucose monitoring platform, the company is positioned to leverage this new capital to enhance its offerings further. The funding will be allocated towards research and development, aimed at refining and expanding Ultrahuman's product suite, which also includes the Ultrahuman Home device for monitoring environmental health markers, and Blood Vision, a pioneering platform for preventive blood testing using UltraTrace™ technology. By combining data from the wearable devices and home health monitoring, Ultrahuman is set to provide users with unique, actionable insights that positively impact metabolic health and overall wellness. This investment marks a pivotal moment for Ultrahuman as it continues to empower individuals on their health journeys, ensuring that self-quantification becomes a seamless and everyday experience. As health becomes an ever-evolving field, Ultrahuman remains committed to being at the forefront, enabling users to gain deeper correlations between their lifestyle and health, leading to improved quality of life and longevity.